-
1دورية أكاديمية
المؤلفون: Jongbloed EM, Blommestein HM, van Schoubroeck HM, Martens JW, Wilting SM, Uyl-de Groot CA, Jager A
المصدر: Breast Cancer: Targets and Therapy, Vol Volume 15, Pp 147-161 (2023)
مصطلحات موضوعية: breast cancer, minimal residual disease, circulating tumor dna, cost-effectiveness, abemaciclib, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
2دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
3دورية أكاديمية
المؤلفون: van Boerdonk RA, Sutedja TG, Snijders PJ, Reinen E, Wilting SM, van de Wiel MA, Thunnissen FE, Duin S, Kooi C, Ylstra B, Meijer CJ, Meijer GA, Grünberg K, Daniels JM, Postmus PE, Smit EF, Heideman DA
المصدر: American Journal of Respiratory & Critical Care Medicine; 10/15/2011, Vol. 184 Issue 8, p948-956, 9p
-
4دورية أكاديمية
المؤلفون: Overmeer, RM, Henken, FE, Snijders, PJF, Claassen-Kramer, D, Berkhof, J, Helmerhorst, TJM, Heideman, DAM, Wilting, SM, Murakami, Y, Ito, A, Meijer, CJLM, Steenbergen, RDM
المصدر: Journal of Pathology; Aug2008, Vol. 215 Issue 4, p388-397, 10p
-
5دورية أكاديمية
المؤلفون: Helmijr J; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, the Netherlands., Motta G; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, the Netherlands.; Department of Clinical and Experimental Medicine, Center for Experimental Oncology and Hematology, University of Catania, Catania, Italy., Jongbloed L; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, the Netherlands., de Weerd V; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, the Netherlands., van Bergen L; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, the Netherlands., Verschoor N; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, the Netherlands., Stella S; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, the Netherlands.; Department of Clinical and Experimental Medicine, Center for Experimental Oncology and Hematology, University of Catania, Catania, Italy., Beaufort C; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, the Netherlands., Vigneri P; Department of Clinical and Experimental Medicine, Center for Experimental Oncology and Hematology, University of Catania, Catania, Italy., Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, the Netherlands., Wilting SM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, the Netherlands., Jansen MPHM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, the Netherlands.
المصدر: The journal of applied laboratory medicine [J Appl Lab Med] 2024 Jul 16. Date of Electronic Publication: 2024 Jul 16.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101693884 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2576-9456 (Print) Linking ISSN: 24757241 NLM ISO Abbreviation: J Appl Lab Med Subsets: MEDLINE
-
6دورية أكاديمية
المؤلفون: Jary A; Department of Pathology, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Cancer Center Amsterdam, Biomarkers and Imaging, Amsterdam, the Netherlands., Kim Y; Department of Pathology, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Cancer Center Amsterdam, Biomarkers and Imaging, Amsterdam, the Netherlands., Rozemeijer K; Department of Pathology, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Cancer Center Amsterdam, Biomarkers and Imaging, Amsterdam, the Netherlands., Eijk PP; Department of Pathology, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Cancer Center Amsterdam, Biomarkers and Imaging, Amsterdam, the Netherlands., van der Zee RP; Department of Pathology, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Department of Internal Medicine, division of Infectious Diseases, Amsterdam UMC, location Universiteit van Amsterdam, Amsterdam, the Netherlands., Bleeker MCG; Department of Pathology, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Cancer Center Amsterdam, Biomarkers and Imaging, Amsterdam, the Netherlands., Wilting SM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Steenbergen RDM; Department of Pathology, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Cancer Center Amsterdam, Biomarkers and Imaging, Amsterdam, the Netherlands. Electronic address: r.steenbergen@amsterdamumc.nl.
المصدر: Experimental and molecular pathology [Exp Mol Pathol] 2024 Jun; Vol. 137, pp. 104906. Date of Electronic Publication: 2024 May 30.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0370711 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-0945 (Electronic) Linking ISSN: 00144800 NLM ISO Abbreviation: Exp Mol Pathol Subsets: MEDLINE
مواضيع طبية MeSH: DNA Copy Number Variations*/genetics , Paraffin Embedding*/methods, Humans ; Female ; High-Throughput Nucleotide Sequencing/methods ; Formaldehyde ; Tissue Fixation/methods ; Whole Genome Sequencing/methods ; Vulvar Neoplasms/genetics ; Vulvar Neoplasms/pathology ; Papillomavirus Infections/genetics ; Papillomavirus Infections/virology ; Papillomavirus Infections/diagnosis ; Anus Neoplasms/genetics ; Anus Neoplasms/diagnosis
-
7دورية أكاديمية
المؤلفون: Bos MK; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Kraan J; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Starmans MPA; Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands., Helmijr JCA; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Verschoor N; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., De Jonge MJA; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Joosse A; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., van der Veldt AAM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands., Te Boekhorst PAW; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Wilting SM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.
المصدر: Molecular oncology [Mol Oncol] 2024 May 24. Date of Electronic Publication: 2024 May 24.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
-
8دورية أكاديمية
المؤلفون: Verschoor N; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. n.verschoor@erasmusmc.nl., Bos MK; Department of Internal Medicine, Breast Cancer Center South Holland South, Ikazia Hospital, Rotterdam, The Netherlands., de Kruijff IE; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Van MN; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Kraan J; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Drooger JC; Department of Internal Medicine, Breast Cancer Center South Holland South, Ikazia Hospital, Rotterdam, The Netherlands., Zuetenhorst JM; Department of Medical Oncology, Franciscus Gasthuis & Vlietland, Rotterdam/Schiedam, The Netherlands., Wilting SM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 May; Vol. 205 (1), pp. 87-95. Date of Electronic Publication: 2024 Jan 31.
نوع المنشور: Journal Article; Clinical Trial, Phase II
بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
مواضيع طبية MeSH: Trastuzumab*/therapeutic use , Neoplastic Cells, Circulating*/metabolism , Breast Neoplasms*/drug therapy , Breast Neoplasms*/pathology , Breast Neoplasms*/mortality , Receptor, ErbB-2*/metabolism , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Taxoids*/therapeutic use , Taxoids*/administration & dosage, Humans ; Female ; Middle Aged ; Aged ; Adult ; Bridged-Ring Compounds/therapeutic use ; Bridged-Ring Compounds/administration & dosage ; Neoplasm Metastasis ; Treatment Outcome ; Biomarkers, Tumor
-
9دورية أكاديمية
المؤلفون: Mens DM; Erasmus MC University Medical Center, Rotterdam, Netherlands. d.mens@erasmusmc.nl., van Rees JM; Erasmus MC University Medical Center, Rotterdam, Netherlands., Wilting SM; Erasmus MC University Medical Center, Rotterdam, Netherlands., Verhoef C; Erasmus MC University Medical Center, Rotterdam, Netherlands.
المصدر: BMC cancer [BMC Cancer] 2023 Dec 04; Vol. 23 (1), pp. 1187. Date of Electronic Publication: 2023 Dec 04.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Quality of Life* , Rectal Neoplasms*/genetics , Rectal Neoplasms*/radiotherapy, Humans ; Chemoradiotherapy/adverse effects ; Chemoradiotherapy/methods ; DNA ; Neoadjuvant Therapy/adverse effects ; Neoadjuvant Therapy/methods ; Neoplasm Staging ; Observational Studies as Topic ; Prospective Studies ; Rectum/pathology ; Treatment Outcome
-
10دورية أكاديمية
المؤلفون: Verschoor N; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. n.verschoor@erasmusmc.nl., Smid M; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Wilting SM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.
المصدر: Breast cancer research : BCR [Breast Cancer Res] 2023 Nov 15; Vol. 25 (1), pp. 145. Date of Electronic Publication: 2023 Nov 15.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE
مواضيع طبية MeSH: Breast Neoplasms*/pathology, Humans ; Female ; Receptor, ErbB-2/genetics ; Receptor, ErbB-2/metabolism ; Mutation ; Gene Expression Profiling/methods ; Genomics/methods ; Transcriptome ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism